RxSight (RXST) Free Cash Flow (2020 - 2026)
RxSight (RXST) posted Free Cash Flow of -$11.6 million for Q1 2026, down 730.96% on a QoQ basis from -$1.4 million in Q4 2025, and down 28.93% year-over-year from -$16.4 million in Q1 2025.
RxSight (RXST) Free Cash Flow (2020 - 2026) Analysis & Trends
RxSight's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$11.6 million for Q1 2026.
- Quarterly Free Cash Flow fell 28.93% year-over-year to -$11.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.5 million (up 7.94% YoY) and the FY2025 annual result came in at -$15.9 million, up 28.83% from the prior year.
- Free Cash Flow was -$11.6 million for Q1 2026 at RxSight, down from -$1.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $790000.0 in Q3 2025 and bottomed at -$18.0 million in Q1 2023.
- A 5-year average of -$9.1 million and a median of -$9.9 million in 2023 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2022 — Free Cash Flow plunged 42.84% — and 2025, when it surged 274.39%.
- RxSight's Free Cash Flow stood at -$12.1 million in 2022, then advanced by 18.4% to -$9.9 million in 2023, then soared by 48.37% to -$5.1 million in 2024, then jumped by 72.55% to -$1.4 million in 2025, then tumbled by 730.96% to -$11.6 million in 2026.
- Business Quant data shows RXST's Free Cash Flow at -$11.6 million in Q1 2026, -$1.4 million in Q4 2025, and $790000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -11.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.65 Mn |
| Mar 31, 2026 | -11.65 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Sep 30, 2025 | 790,000.00 |
| Sep 30, 2025 | 790,000.00 |
| Jun 30, 2025 | -6.28 Mn |
| Jun 30, 2025 | -6.28 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Mar 31, 2025 | -9.04 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Dec 31, 2024 | -5.11 Mn |
| Sep 30, 2024 | -453,000.00 |
| Sep 30, 2024 | -453,000.00 |
| Jun 30, 2024 | -5.55 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | -11.28 Mn |
| Mar 31, 2024 | -11.28 Mn |
| Dec 31, 2023 | -9.89 Mn |
| Dec 31, 2023 | -9.89 Mn |